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Fetal epithelium retains the ability to re-epithelialize a wound in organotypic culture in a manner not dependent on
the presence of underlying dermal substrata. This capacity is lost late in the third trimester of gestation or after
embryonic day 17 (E17) in the rat such that embryonic day 19 (E19) wounds do not re-epithelialize. Moreover,
wounds created in E17 fetuses in utero heal in a regenerative, scar-free fashion. To investigate the molecular events
regulating re-epithelialization in fetal skin, the wound-induced expression proﬁle and tissue localization of
activator protein 1 (AP-1) transcription factors c-Fos and c-Jun was characterised in E17 and E19 skin using
organotypic fetal cultures. The involvement of mitogen-activated protein kinase (MAPK) signaling in mediating
wound-induced transcription factor expression and wound re-epithelialization was assessed, with the effect of
wounding on the expression of keratinocyte differentiation markers determined. Our results show that expression
of AP-1 transcription factors was induced immediately by wounding and localized predominantly to the epidermis
in E17 and E19 skin. c-fos and c-jun induction was transient in E17 skin with MAPK-dependent c-fos expression
necessary for the re-epithelialization of an excisional wound in organotypic culture. In E19 skin, AP-1 expression
persisted beyond 12 h post-wounding, and marked upregulation of the keratinocyte differentiation markers keratin
10 and loricrin was observed. No such changes in the expression of keratin 10 or loricrin occurred in E17 skin.
These ﬁndings indicate that re-epithelialization in fetal skin is regulated by wound-induced AP-1 transcription
factor expression via MAPK and the differentiation status of keratinocytes.
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The re-epithelialization of wounded skin completes the
acute phase of wound healing and is responsible for
restoring skin barrier function. The re-epithelialization
process requires wound-edge keratinocytes to undergo
directional migration to initially cover the wound defect and
then proliferate and differentiate to re-establish a normal,
stratified epithelium with its protective, keratinized layer
(Stenn et al, 1992). To achieve this, keratinocytes in adult
skin migrate across a wound by anchoring to the
substratum and crawling over it via extended lamellipodia
(Martin and Lewis, 1992). In fetal skin however, re-
epithelialization appears to proceed independently of
dermal substrata. That is, keratinocytes at the margin of a
wound in fetal skin are drawn toward the center of the
wound by contraction of an actin cable, in a purse string-
like fashion (Martin and Lewis, 1992). Like re-epithelializa-
tion, dermal repair has been found to proceed by
fundamentally different mechanisms in fetal and adult skin.
Dermal repair in adult skin primarily involves a fibrotic
process resulting in scar formation, whereas in fetal skin,
healing occurs more by regeneration of dermal structures
(Adzick et al, 1994).
Studies have shown that excisional wounds created in
skin from embryonic day 17 (E17) rats heal completely in
explant culture due to the formation of an epithelial bridge
across the wound (Ihara et al, 1990; Belford, 1997). This
occurs due to keratinocytes from this skin possessing a
unique ability to migrate into the wound without the
structural base provided by components of the extracellular
matrix, and appear to use the cytoskeletal rearrangement of
actin and its condensation for directional control (Cowin
et al, 2003). Wounds created in skin excised from E19 rats
however do not close, other than showing a limited degree
of dermal contraction (Ihara et al, 1990; Belford, 1997).
Thus, skin from E19 fetuses appears to replicate re-
epithelialization observed in adult skin, whereby keratino-
cytes can only migrate across dermal substrata that has
been deposited to fill a wound deficit. Little is known about
Abbreviations: AP-1, activator protein 1; ERK, extracellular signal-
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the wound-induced molecular or cellular events that control
the differential capacity of keratinocytes from E17 and E19
skin to migrate and close a wound.
Cell migration and wound re-epithelialization are con-
trolled in part by a number of genes regulated by activator
protein 1 (AP-1) (Jaakkola et al, 1998; Tran et al, 1999), one
of the main downstream targets of mitogen-activated
protein kinases (MAPK) (Whitmarsh and Davis, 1996). These
genes, which all contain AP-1 binding sites in their
promoters, include transforming growth factor b1 (Birche-
nall-Roberts et al, 1990), collagenase enzymes (White et al,
1995; Gum et al, 1997), a6 integrin (Nishida et al, 1997), and
b4 integrin (Takaoka et al, 1998). Rapid expression of AP-1
components, generally c-Fos, has been demonstrated in
response to wounding in cultured renal (Pawar et al, 1995),
intestinal (Dieckgraefe et al, 1997) and corneal epithelial
cells (Okada et al, 1996), as well as endothelial cells
(Feldman et al, 1992; Tran et al, 1999) and fibroblasts
(Verrier et al, 1986; Tsuboi et al, 1990). AP-1 transcription
factor induction has also been reported in embryonic
mouse skin (E12.5), with c-Fos protein upregulated in the
epidermis 15 min after wounding (Martin and Nobes, 1992;
Brock et al, 1996). This increase is coupled to G-protein
signaling via Rho GTPase that has also been linked to the
formation of actin cables in keratinocytes at the margin of
these wounds. Actin cables formed in embryonic mouse
skin are seen to run continuously around the wound and are
restricted to a single row of basal keratinocytes at the
wound edge (Martin and Lewis, 1992). This localization of
actin was also observed around an excisional wound in
explant E17 but not E19 fetal rat skin (Cowin et al, 2003). On
the other hand, G protein signaling via Rac and Cdc42
specifically associates with the cytoskeletal rearrangement
of actin resulting in the formation of lamellipodia and
filopodia respectively (Nobes and Hall, 1995), hallmarks of
migrating keratinocytes from adult skin (Martin and Lewis,
1992). Thus, signaling cues induced by wounding may
mediate the downstream changes in keratinocytes that
appear to be associated with the differential capacity of E17
and E19 epidermis to close a wound in the absence of
dermal substrata.
In vitro assessment of wound-induced signaling using
normal human keratinocytes showed that MAPK activation
was associated with AP-1 transcription factor expression,
concomitant DNA binding activity of several Fos/Jun com-
plexes, and the induction of AP-1-regulated genes (Turchi
et al, 2002). While these studies support the putative role
for MAPK/AP-1 signaling in controlling wound-induced cell
activation and subsequent events such as re-epithelialization
(Yates and Rayner, 2002), this has yet to be confirmed in skin.
Examination of the coordinated expression of genes from the
Fos and Jun families, as is required to form the heterodimeric
complex necessary for functional AP-1 (Curran and Franza,
1988), has not previously been determined in wounded adult
or fetal skin. Similarly, the G protein-associated kinase
cascades likely to be involved in translocating the wound
stimulus into the nucleus to drive AP-1 activation have
not been investigated in skin despite this being a critical
intermediate process, because transcription of genes like c-
fos can be downstream of multiple signaling pathways
(Whitmarsh and Davis, 1996; Leppa¨ et al, 1998).
Aside from a change in the capacity of epithelium from
E17 and E19 fetuses to re-epithelialize a wound, a major
alteration in the differentiation status of the epidermis also
occurs over this gestational period. While E17 keratinocytes
show little evidence of terminal differentiation, the develop-
ment of a stratified epithelium and the acquisition of barrier
function is apparent by day 20 (Hardman et al, 1998;
Williams et al, 1998). AP-1 transcription factors are
intimately involved in regulating keratinocyte differentiation
(Fisher et al, 1991; Welter and Eckert, 1995). This is
emphasized by the number of cytokeratin and differentia-
tion-specific genes which have AP-1 sites in their promoters
such as keratin 1, 5, and 14, loricrin, filaggrin and involucrin
(Casatorres et al, 1994; Lu et al, 1994; DiSepio et al, 1995;
Welter et al, 1995; Jang et al, 2000; Sinha et al, 2000).
Wounding and subsequent re-epithelialization is thought,
however, to interrupt the terminal differentiation of kerati-
nocytes (Paladini et al, 1996). In adult skin, suprabasal
keratinocytes show upregulated expression of keratin 6, 16,
and 17 in what is suggested to be an activation phase
responsible for preparing the keratinocytes for migration
(Paladini et al, 1996). The effect of wounding on keratino-
cyte differentiation in fetal skin has not been examined
previously.
To improve the understanding of the early molecular
events involved in wound re-epithelialization in fetal skin,
this study measured the time course of wound-induced
AP-1 transcription factor expression in E17 and E19 skin and
examined the role of MAPK activation in mediating c-fos
expression and wound re-epithelialization. As a secondary
aim, we also sought to associate wound-induced changes
in AP-1 transcription factor expression with the differentia-
tion status of the fetal keratinocytes. Our results suggest
that age-dependent, wound-induced activation of AP-1
transcription factors via MAPK differentially regulates
keratin gene expression in fetal skin. We postulate that
a change in keratinocyte differentiation, consistent with
progression toward terminal differentiation in E19 skin but
not E17 skin, may influence the capacity of fetal skin to re-
epithelialize a wound in the absence of dermal substrata.
Results
Wound-induced transcription factor expression To in-
vestigate the potential of the AP-1 transcription factor to
mediate immediate-early molecular responses to wounding
in E17 and E19 skin, the wound-induced expression profile
of c-fos and c-jun was examined. These studies were
performed using skin excised from the fetuses and
incubated in serum-free media (DMEM only) to ensure that
transcription factor expression could only be induced by
wounding and not by mitogenic factors contained in FBS.
Fetal skin incubated in serum-free media has previously
been shown to remain viable with no evidence of tissue
degradation for up to 3 d in similar cultures (Belford, 1997).
Northern blot analysis showed very low levels of
endogenous c-fos mRNA expression (time zero) in both
E17 and E19 skin despite the presence of abundant GAPDH
control message (Fig 1a, b). When fetal skin was wounded
and maintained in explant culture for up to 24 h, distinctly
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different c-fos expression profiles were observed in E17 and
E19 skin. Wounding caused a dramatic but transient
upregulation of c-fos mRNA expression in E17 skin that
was statistically different from control values after 30 min
(po0.05). Wound-induced c-fos expression decreased
rapidly, with the level at 90 min being significantly different
from that at 30 min (po0.05), although expression levels
remained significantly elevated compared to control until
6 h (Fig 1a, c).
Wounding also stimulated an immediate increase in c-fos
expression in E19 skin that was significant after 30 min
(po0.05); however, the response persisted longer with c-fos
expression maintained at high levels for at least 12 h (Fig 1b,
c). Indeed, wound-induced expression was still significantly
different from control at 24 h, with 12 h being the first time
point post-wounding to show a significant decrease in c-fos
expression compared to 30 min (po0.05, Fig 1c). Two-way
ANOVA confirmed that the c-fos expression profiles of E17
and E19 skin were statistically different (po0.001), and post
hoc analysis found that comparisons of c-fos expression
between E17 and E19 skin at time points from 60 min to 12 h
were significantly different (po0.05).
As with c-fos, very low levels of steady-state c-jun
expression were evident in both unwounded E17 and E19
skin with wounding stimulating characteristic expression
profiles (Fig 2). In E17 skin, wounding induced expression of
the two c-jun transcripts (2.7 and 3.2 kb) that peaked by
30 min but then decreased to remain at a level of expression
approximately 2-fold higher than baseline after 3 h although
statistical significance was not achieved (Fig 2c). Wounding
E19 skin induced a biphasic increase in c-jun expression
that initially rose to a plateau between 1 and 3 h post-
wounding and then increased further to be significantly
Figure 1
Temporal expression profile of c-fos mRNA induced by wounding
in fetal skin. Wounded skin explants from the dorsum of E17 and E19
fetal rats were incubated for up to 24 h in serum-free media. Total RNA
from tissue collected at the indicated times was assessed for c-fos and
GAPDH expression by northern blot. Representative autoradiograms of
c-fos and the corresponding GAPDH expression are shown for E17 (a)
and E19 skin (b). Densitometric analysis was performed on replicate
samples at each time point for both E17 (  ) and E19 (  ) skin and c-fos
expression shown as a ratio of GAPDH expression (c). Values represent
mean  SEM (n¼ 3) for both E17 and E19 skin. Two-way ANOVA was
used to determine statistical significance. Data points significantly
different (po0.05) from control (0 h) are shown for E17 (a) and E19 (b)
skin with differences between E17 and E19 at individual time points also
shown ().
Figure2
Temporal expression profile of c-jun mRNA induced by wounding
in fetal skin. Wounded skin explants from the dorsum of E17 and E19
fetal rats were incubated for up to 24 h in serum-free media. Total RNA
from tissue collected at the indicated times was assessed for c-jun and
GAPDH expression by northern blot. Representative autoradiograms of
c-jun and the corresponding GAPDH expression are shown for E17 (a)
and E19 skin (b). Densitometric analysis was performed on replicate
samples at each time point for both E17 (  ) and E19 (  ) skin and c-jun
expression shown as a ratio of GAPDH expression (c). Values represent
mean  SEM (n¼3) for both E17 and E19 skin. Two-way ANOVA was
used to determine statistical significance. Data points significantly
different (po0.05) from control (0 h) are shown for E19 skin (b).
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different from steady-state controls after 12 h (po0.05;
Fig 2b, c). Although the smaller 2.7 kb transcript was expres-
sed at much higher levels, both transcripts appeared to
change in parallel and were combined for phosphorimage
quantitation (Fig 2c). Two-way ANOVA confirmed that the
profile of c-jun expression in E17 and E19 skin was signi-
ficantly different (po0.001).
As excising the skin creates a wound and prevents direct
comparison with unwounded, time-matched controls, addi-
tional experiments were performed to ensure that wounding
and not fetus-to-culture transfer specifically induced c-fos
gene expression. Skin was excised from E17 fetuses and
incubated without additional wounding for 3, 4, and 6 h
(when c-fos was shown to be returning towards basal levels
in Fig 1), and then replicate pieces of skin were either
wounded (as previously described) or left unwounded and
incubated for a further 30 min. Compared to the time-
matched controls that did show residual c-fos expression
(induced by excising the skin), additional wounding mark-
edly stimulated c-fos expression (Fig 3a). As shown in
Fig 3b, the wound-induced expression profile of c-fos
obtained when the skin was wounded 6 h after excision was
similar to that observed in Fig 1. Compared to the time-
matched, unwounded controls, c-fos expression was
significantly increased after 30 min and gradually declined
to near basal levels over 3 h (Fig 3c).
Wound-induced ERK activation and wound closure To
determine if wounding induced AP-1 transcription factor
expression via MAPK activation and whether this signal
transduction pathway could indeed mediate wound re-
epithelialization in E17 skin, experiments were performed
using the MEK inhibitor U0126 (Favata et al, 1998). MEK is
the primary kinase responsible for phosphorylating and
activating ERK (Whitmarsh and Davis, 1996), and activated
(phosphorylated) forms of the ERK1 and ERK2 proteins
were examined by western blot in skin extracts obtained
from short-term culture experiments using whole fetuses
that were incubated in DMEM only (to ensure that serum-
induced activation of ERK did not confound the results). The
steady-state levels of phosphorylated ERK1 and ERK2 were
found to be relatively low in both E17 and E19 skin, despite
the high abundance of ERK1 and ERK2 proteins, with ERK2
being the predominant, active form in E17 skin (Fig 4a, b).
Wounding significantly increased the phosphorylation of
both ERK1 and ERK2 after 5 min (po0.05), and co-
incubation of fetuses with media containing the MEK
inhibitor U0126 (including a 10 min pre-incubation prior to
wounding to allow permeation of the inhibitor into the skin
cells) completely abolished all phosphorylation of ERK1 and
significantly inhibited wound-induced activation of ERK2 at
both doses used in E17 skin (po0.05; Fig 4a, b). The total
ERK1 and ERK2 protein levels were found to be consistent
between samples and were used to normalize the respec-
tive phosphorylated ERK activities (Fig 4b). U0126 de-
creased wound-induced ERK1 and ERK2 in E19 skin but
only at the highest dose used (Fig 4a), suggesting the
increased barrier function associated with the more mature,
differentiated state of the skin at this gestational age may
have limited its availability and uptake by the cells.
To determine if wound-induced ERK phosphorylation
regulated AP-1 transcription factor expression, the ability of
the MEK inhibitor to modify c-fos and c-jun induction using
E17 fetal culture was investigated. Incubation of whole,
wounded fetuses in DMEM containing two concentrations
of U0126 inhibited the wound-induced expression of c-fos
in the skin after 30 min but had little effect on c-jun (Fig 4c).
As this result indicated that wound-induced ERK activation
is involved in stimulating c-fos expression, wounded E17
skin explants were incubated in media with or without the
MEK inhibitor to determine if wound re-epithelialization was
Figure3
Comparative expression of c-fos mRNA in unwounded and
wounded excised skin. Skin was excised from the dorsum of E17
fetal rats, incubated for 3, 4, and 6 h in serum-free media, and then
either left unwounded () or wounded (þ ) and incubated for a further
30 min. Total RNA from tissue collected at the indicated times was
assessed for c-fos and GAPDH expression by northern blot and
representative autoradiograms shown (a). Replicate pieces of excised
skin incubated for 6 h were either left unwounded (control) or wounded
and then incubated for the additional times indicated, and assessed for
c-fos and GAPDH expression (b). Densitometric analysis was
performed on replicate samples at each time point for unwounded
(control; open bars) or wounded skin (closed bars) (c) Values represent
mean  SEM (n¼3), and one-way ANOVA was used to determine
statistical significance between control and wounded skin (; po0.05).
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dependent on this pathway. In these experiments, mounted
skins were incubated in serum-supplemented media (10%
FBS), as previous studies have shown that prolonged
mitogenic support is required to elicit full wound re-
epithelialization via actin-mediated events in this model
(Belford, 1997; Cowin et al, 2003). This was confirmed as
wounded skin incubated in serum-free media showed no
change over the culture period (Fig 5a, panels A and B),
whereas incubation of skins in serum-supplemented media
resulted in approximately 80% closure or re-epithelialization
of the wounds after 24 h (Fig 5a, panels C and D). To ensure
complete inhibition and account for any ERK activation that
may result from the addition of serum in these studies, a
higher U0126 dose (50 mM) was used and its addition to
the culture media clearly reduced the amount of wound
Figure 4
Effect of U0126 on ERK phosphorylation and c-fos mRNA
expression in skin from fetal rats. Whole E17 and E19 fetuses were
incubated in serum-free media for 10 min with or without () the
addition of U0126 (10 or 20 mM), skin on the dorsal region of the fetuses
was wounded (þ ) or left unwounded (), and the whole fetus was
incubated for a further 5 min. The dorsal area of the skin was then
excised and protein extracts were assessed for ERK1 and ERK2
phosphorylation by western blot. (a) Representative blots of phos-
phorylated ERK1 and ERK2 as well as total ERK1 and ERK2 protein
expression are shown. (b) Densitometric analysis was performed on
replicate blots of protein from E17 skin and phosphorylated ERK bands
normalized to the respective total ERK protein and the mean  SEM
(n¼ 3) shown with ERK1 represented by the open bars and ERK2 by
the closed bars. Statistical analysis was performed using one-way
ANOVA and post hoc all pairwise t-test comparison. Significant
differences (po0.05) between treatments are shown by matching the
same symbol for ERK1 or ERK2 (differences between ERK1 and ERK2
were not assessed). (c) To examine c-fos and c-jun mRNA expression,
total RNA was extracted from skin collected 30 min after wounding (þ )
that had been treated with or without () the indicated dose of U0126.
Total RNA was assessed for c-fos, c-jun, and GAPDH mRNA expres-
sion by northern blot and representative autoradiograms shown.
Figure5
Effect of U0126 on wound re-epithelialization in skin from E17
fetuses. A single excisional wound was created using a blunted 19-
gauge needle in the middle of a 1 cm  1 cm region of skin removed
from the dorsum of E17 fetuses. The skin was mounted onto a solid
support with pins to retain its normal tension and placed in a 12-well
tissue culture dish containing 4 mL of media and incubated for up to 24
h at 371C in 5% CO2–air. (a) Images of the wound in skin explants were
captured at the time of wounding (panels A, C, E) and corresponding
images were captured after 24 h incubation in serum-free media (B),
media supplemented with 10% FBS (D), and supplemented media
containing 50 mM U0126 (F). Scale bar¼0.5 mm. (b) The size of the
wounds was calculated using image analysis software and the degree
of wound re-epithelialization determined relative to the original wound
area. The change in wound size observed after 24 h in skin incubated in
serum-free media (filled bar) or media supplemented with 10% FBS
with or without 50 mM U0126 is shown. Values represent the
mean  SEM (n¼5–6) and statistical significance (; po0.05) deter-
mined by one-way ANOVA and post hoc t test comparison with the
serum-free controls.
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re-epithelialization (Fig 5a, panels D and F). The measure-
ment of residual wound areas after 24 h confirmed these
observations as only the wounds in skin incubated with
serum-supplemented media were significantly smaller
(po0.05) than the serum-free controls (Fig 5b). Wounds in
skin co-incubated with U0126 showed only a small degree
of re-epithelialization (approximately 25% closure after 24 h)
and were not statistically different from the wounds in
serum-free, control skins (Fig 5b).
Wound-induced c-Fos localization To examine the loca-
lization of c-fos mRNA in the skin, in situ hybridization was
performed on sections from E17 and E19 fetuses that were
collected after incubation in serum-free media for 30 and 60
min post-wounding respectively, corresponding to maximal
wound-induced c-fos mRNA levels by northern blot (Fig 1).
Immunohistochemistry was also performed to determine
the localization of c-Fos protein in E17 and E19 skin and
confirm the wound-induced temporal expression of c-Fos
in E17 skin. Steady-state expression of c-fos mRNA was
localized predominantly to the nucleus of epidermal cells in
skin collected at the time of wounding from E17 fetuses
(Fig 6a), and this expression increased dramatically com-
pared to unwounded, time-matched controls 30 min after
wounding (Fig 6b and c respectively). The staining remained
nuclear in origin and, despite the marked increase in
expression that was equally distributed throughout the
layers of the epidermis and extended beyond the cells at
the edge of the wound, there was no generalized increase in
staining in the dermal fibroblasts (Fig 6c). Wounded skin
incubated with control probe was negative (Fig 6d).
When c-Fos protein localization was assessed by
immunohistochemistry, minimal expression was found in
control E17 skin collected at the time of wounding (Fig 6e).
c-Fos positive fluorescence was markedly increased,
however, in the epidermis 60 min after wounding (Fig 6f),
with some positive staining also evident in the dermis and
underlying subcutaneous tissue. The positive staining was
predominantly nuclear and present in all layers of the
epidermis and was transient, reaching a peak at 90 min
(Fig 6g) with expression decreasing to low levels again by
3 h (Fig 6h). Sections incubated without antibody were
negative (not shown).
Figure 7 shows that steady-state expression of c-fos
mRNA in skin collected at the time of wounding from E19
fetuses also localized predominantly to the nucleus of
epidermal cells (Fig 7a). Compared to time-matched,
unwounded skin (Fig 7b), expression increased dramatically
60 min after wounding and showed a diffuse, cytoplasmic
distribution that was most apparent in the suprabasal cells
(Fig 7c). As with E17 skin, there was no generalized increase
in staining in the dermal fibroblasts and sections of
wounded skin incubated with control probe were negative
(Fig 7d). When c-Fos protein localization was assessed by
immunohistochemistry, minimal expression was found in
control E19 skin collected at the time of wounding (Fig 7e).
Compared to time-matched, unwounded control skin
(Fig 7f), c-Fos staining was increased in the epidermis
60 min after wounding and was found to have a pre-
dominantly cytoplasmic and perinuclear localization in
suprabasal cells at the wound margin, with some positively
stained basal cells evident further away from the wound (Fig
7g). Minimal positive staining was observed in the dermis
and sections of wounded skin incubated without antibody
were negative (Fig 7h).
Wound-induced keratin expression Given that wound-
induced c-Fos expression was localized to the epidermis of
both E17 and E19 skin, we investigated the effect of
wounding on the regulation of keratinocyte differentiation
by examining the expression of the differentiation markers
keratin 14, keratin 10, and loricrin. Figure 8 shows that
immunostaining for keratin 14 at the time of wounding was
primarily restricted to basal epidermal cells in both E17 and
E19 skin, although some suprabasal cells appeared to be
positive in E19 skin (Fig 8a and c respectively). The staining
pattern did not change after wounding with Fig 8b (E17) and
Fig 8d (E19) showing keratin 14 immunoreactivity 3 h post-
wounding, a similar result was obtained after 6 h. Sections
incubated without antibody were negative (data not shown).
Keratin 14 mRNA levels were also unaffected by wounding
for the first 3 h in E17 skin and 6 h in E19 skin, with a gradual
downregulation observed after this time in each tissue
(Fig 8e and f). A significant decrease compared to control
values, however, was only obtained after 24 h (data not
shown).
Keratin 10 expression was analyzed as a gene marker
associated with cells committing to terminal differentiation,
and loricrin was examined as a gene marker expressed
exclusively by terminally differentiated cells. Wounding had
no immediate effect on keratin 10 expression in E17 skin, but
appeared to induce a gradual reduction in mRNA levels over
the 24 h post-wounding although this was found not to be
significant (Fig 9a, c). In E19 skin however, keratin 10
expression had begun to increase by 3 h post-wounding
and continued to rise until 24 h, where it was significantly
different (approximately 3-fold higher, po0.05) from basal
levels (Fig 9b, c). All pairwise comparison showed that
keratin 10 expression after 24 h was also statistically
different from expression levels obtained after 30, 60, and
90 min but not 3, 6, and 12 h (Fig 9c). Two-way ANOVA
confirmed that the keratin 10 expression profiles of E17 and
E19 skin were statistically different (po0.001), and post hoc
analysis found that comparisons of keratin 10 expression
between E17 and E19 skin at time points from 3 to 24 h were
significantly different (po0.05; Fig 9c).
Loricrin was only expressed at very low levels in E17 skin
and did not change with wounding (Fig 10a, c). Steady-state
loricrin expression was also low in E19 skin, with upregula-
tion being evident in the first 60 min post-wounding and a
significant increase compared to control values observed
after 90 min (po0.05; Fig 10b, c). A dramatic 12-fold
upregulation was seen after 3 h, and although a further
increase was apparent after 12 h, all pairwise analysis found
that expression levels at 3, 6, 12 and 24 h were not
significantly different from each other (Fig 10c). Even though
loricrin expression appeared to have declined after 24 h in
E19 skin, it was still significantly greater (5-fold, po0.05)
than controls (Fig 10c). Two-way ANOVA confirmed that the
wound-induced loricrin expression profiles of E17 and E19
skin were statistically different (po0.001), and post hoc
analysis found that comparisons of loricrin expression
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between E17 and E19 skin at time-points from 30 min to 24 h
were significantly different (po0.05; Fig 10c).
Discussion
In this study, we have shown that the temporal expression
of AP-1 transcription factors c-Fos and c-Jun in response to
wounding is different in skin from E17 and E19 rat fetuses.
Our results demonstrate that inhibition of wound-induced
MAPK phosphorylation in E17 skin suppressed c-fos
expression and prevented wound re-epithelialization. More-
over, wounding augmented the expression of the keratino-
cyte differentiation markers keratin 10 and loricrin in E19
skin, suggesting that prolonged induction of AP-1 factors
following wounding in this tissue promoted keratinocyte
differentiation. Conversely, the transient, MAPK-dependent
AP-1 expression observed in E17 skin was not associated
with upregulation of keratinocyte differentiation genes,
suggesting that these epidermal cells may be preferentially
Figure 6
Localization of c-Fos in E17 rat skin. A
single linear incision was created on the
dorsum of E17 fetuses, which were
subsequently incubated in serum-free
media. In situ hybridization was per-
formed for c-fos mRNA, and images
show staining of skin collected at the
time of wounding (a), unwounded control
skin incubated for 30 min (b), wounded
skin incubated for 30 min (c), and
wounded skin incubated for 30 min
stained with a control RNA probe (d).
Immunohistochemistry also was per-
formed on sections of E17 fetuses, and
images show c-Fos protein in skin from
fetuses collected at the time of wound-
ing (e), and post-wounding 60 min (f), 90
min (g) and 3 h (h). The epidermis (e),
wound margin (w) and the basement
membrane zone (bmz) are shown. Scale
bar a–d¼ 10 mM and e–h¼20 mM.
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induced to migrate rather than differentiate, resulting in their
enhanced ability to affect wound re-epithelialization.
The importance of c-Fos and other AP-1 transcription
factors in embryonic growth and development has been
supported by a number of studies that show temporal- and
organ-specific expression patterns for these regulatory
molecules during embryogenesis (Muller et al, 1982; Dony
and Gruss, 1987). Upregulated expression of c-fos mRNA
during skin development has been reported to coincide with
the onset of keratinization late in the third trimester of
gestation (Fisher et al, 1991), with high levels present in
neonatal mouse skin (Muller et al, 1982) and human adult
skin (Basset-Seguin et al, 1990, 1991). In our study, only a
very low steady-state level of c-fos and c-jun expression
was detected in skin from either E17 and E19 fetuses, but
expression of both transcription factors was rapidly induced
following wounding, consistent with studies examining
c-Fos in other systems (Martin and Nobes, 1992; Pawar
et al, 1995; Okada et al, 1996; Dieckgraefe et al, 1997).
Although the rapid induction of c-Fos has been identified as
a seemingly universal response in skin cells to wounding,
our finding that c-fos and c-jun expressions are both
induced in fetal skin supports the potential for heterodimeric
complexes of these transcription factors to be formed
and initiate downstream AP-1-regulated gene expression
(Curran and Franza, 1988). More specifically, the temporal
mRNA and protein expression profiles observed here
indicate that the regulation of AP-1-controlled genes
in E17 skin would most likely be transient, with maximal
activity observed approximately 90 min after wounding but
Figure 7
Localization of c-Fos in E19 rat skin. A single
linear incision was created on the dorsum of E19
fetuses, which were subsequently incubated in
serum-free media. In situ hybridization was
performed for c-fos mRNA, and images show
staining of skin collected at the time of wounding
(a), unwounded control skin incubated for 60 min
(b), wounded skin incubated for 60 min (c), and
wounded skin incubated for 60 min stained with
a control RNA probe (d). Immunohistochemistry
also was performed on sections of E19 fetuses,
and images show c-Fos protein in skin from
fetuses collected at the time of wounding (e),
unwounded control skin incubated for 60 min (f),
wounded skin incubated for 60 min (g), and
wounded skin incubated for 60 min as a negative
staining control (h). The epidermis (e), wound
margin (w), and the basement membrane zone
(bmz) are shown. Scale bar a–d¼10 mM and
e–h¼ 20 mM.
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unlikely to persist much beyond 3 h. Regulation of down-
stream gene transcription in E19 skin would also reach
significant levels from about 90 min post-wounding but, in
contrast to E17 skin, would be expected to persist at least
up to 12 h.
While the duration of the signaling events mediating the
expression of transcription factor mRNA has been impli-
cated as a critical step in determining downstream cellular
effects, the complex but ill-defined processes controlling
degradation of the AP-1 proteins responsible for DNA
binding and subsequent transactivation are also likely to
play a signficant role (Salvat et al, 1998). The transient
activation of protein kinases resulting in the type of
expression profile observed in wounded E17 skin has been
proposed to initiate a proliferative response, and the
sustained co-expression of c-Fos and c-Jun similar to that
observed in E19 skin has been associated with prominent
changes in AP-1-controlled gene transcription (Trejo et al,
1992; Marshall, 1995). Indeed, the somewhat biphasic
wound-induced expression of c-jun in E19 skin is remark-
ably similar to that observed following thrombin receptor
activation in astrocytoma cells. In these studies, induction
of c-Fos coupled with the sustained co-expression of c-Jun
was required for AP-1 DNA-binding activity and transacti-
vation through AP-1 (Trejo et al, 1992). In human keratino-
cytes, the prolonged expression of c-Fos has been
identified as the likely switch responsible for their com-
mitment to terminal keratinization (Basset-Seguin et al,
1994).
The potential of wound-induced c-Fos via AP-1 to
modulate keratinocyte differentiation in fetal skin is sup-
ported by our in situ hybridization and immunohistochem-
istry results, which demonstrate that c-Fos expression was
found predominantly in epithelial cells at the wound edge. In
addition, c-fos mRNA in E19 skin was seen mainly in
suprabasal keratinocytes at the wound margin, consistent
with AP-1 regulation of terminal keratinization (Fisher et al,
1991). While the wound-induced in situ hybridization
expression of c-fos appeared predominantly cytoplasmic
in E19 skin, it was restricted to the nucleus in E17 skin. The
transportation of c-fos transcripts to the nuclear envelope
takes about 15 min (Huang and Spector, 1991) and
Figure 8
Expression of keratin 14 in wounded
fetal rat skin. A single linear incision was
created on the dorsum of E17 and E19
fetuses, which were subsequently incu-
bated in serum-free media. Immuno-
histochemistry for keratin 14 was
performed, and images show immuno-
fluorescence localized in the epidermis
(e) adjacent to the wound margin (w) in E17
skin at the time of wounding (a) and 3 h
post-wounding (b), and E19 skin at the
time of wounding (c) and 3 h post-
wounding (d). The basement membrane
zone (epidermis/dermis interface) is
also shown (bmz). Scale bar¼20 mM.
Wounded skin explants from the dorsum
of E17 and E19 fetal rats were incubated
for up to 24 h in serum-free media. Total
RNA from tissue collected at the indi-
cated times was assessed for keratin 14
and GAPDH expression by northern blot.
Representative autoradiograms of kera-
tin 14 and the corresponding GAPDH
expression are shown for E17 (e) and E19
skin (f).
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cytoplasmic c-fos has a half-life of around 10 min
(Rahmsdorf et al, 1987; Shyu et al, 1989). Thus, if
expression is initiated within the first 10–15 min following
wounding (as suggested by our ERK results that show
MAPK activation after 5 min) and is maximal after 30 min (as
shown by our northern blot data), then most of these
transcripts could be expected to be found in the nucleus as
shown in Fig 6c.
Our studies also demonstrate that wounding resulted in
markedly upregulated keratin 10 and loricrin mRNA expres-
sion in E19 skin, and this was evident at a time consistent
with the anticipated initiation of AP-1 regulation in this tissue
(i.e., from 90 min post-wounding). Thus, the wound-
induced, sustained expression of AP-1 factors would
appear to promote terminal differentiation in this tissue,
particularly as the transitory AP-1 response observed in E17
skin was not associated with any major change in keratin 10
or loricrin levels. We consider that the activation of the
differentiation genes was a specific response to wounding
and not just representative of the changes expected in skin
at E19–20, because experiments were performed using
fetuses from different litters and we observed time-
dependent (post-wounding) statistically significant effects.
If the activation was due to developmental processes, the
variation between litters (of up to 6 h) would have eliminated
the time dependence of these responses.
Figure 9
Temporal expression profile of keratin 10 mRNA induced by
wounding in fetal skin. Wounded skin explants from the dorsum of
E17 and E19 fetal rats were incubated for up to 24 h in serum-free
media. Total RNA from tissue collected at the indicated times was
assessed for keratin 10 and GAPDH expression by northern blot.
Representative autoradiograms of keratin 10 and the corresponding
GAPDH expression are shown for E17 (a) and E19 skin (b). Densitometric
analysis was performed on replicate samples at each time point for
both E17 (  ) and E19 (  ) skin and keratin 10 expression shown as a
ratio of GAPDH expression (c). Values represent mean  SEM (n¼3)
for both E17 and E19 skin. Two-way ANOVA was used to determine
statistical significance. Data points significantly different (po0.05) from
control (0 h) are shown for E19 skin (b) with differences between E17 and
E19 at individual time points also shown (
).
Figure10
Temporal expression profile of loricrin mRNA induced by wounding
in fetal skin. Wounded skin explants from the dorsum of E17 and E19
fetal rats were incubated for up to 24 h in serum-free media. Total RNA
from tissue collected at the indicated times was assessed for loricrin
and GAPDH expression by northern blot. Representative autoradio-
grams of loricrin and the corresponding GAPDH expression are shown
for E17 (a) and E19 skin (b). Densitometric analysis was performed on
replicate samples at each time point for both E17 (  ) and E19 (  ) skin
and loricrin expression shown as a ratio of GAPDH expression (c).
Values represent mean  SEM (n¼ 3) for both E17 and E19 skin. Two-
way ANOVA was used to determine statistical significance. Data points
significantly different (po0.05) from control (0 h) are shown for E19 skin
(b) with differences between E17 and E19 at the indicated time points
also shown ().
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The capacity of AP-1 to regulate loricrin is established,
given this gene contains an AP-1 site in its promoter and AP-
1 transcription factors are known to be important for
modulating its expression in human keratinocytes (DiSepio
et al, 1995; Jang and Steinert, 2002); however, a role in
controlling keratin 10 expression is speculative given that no
AP-1 sites have been identified in the keratin 10 promoter. In
our studies, upregulation of this gene appeared to be
initiated an hour or so after loricrin, suggesting that an
intermediate, AP-1-dependent event may be involved in
mediating its wound-related transcription, particularly as a
number of keratinocyte differentiation-specific genes are
controlled by interactions between different regulatory
proteins (Angel et al, 2001). Such interactions may also
explain the changes we saw in keratin 14 expression. AP-1
activation and the induction of keratinocyte differentiation is
generally associated with the repression of keratin 14
expression (Rutberg et al, 1996; Angel et al, 2001). As c-Fos
and keratin 14 were co-localized in basal keratinocytes in E17
skin, it is possible that AP-1 mediated the gradual decrease
in keratin 14 expression observed in this tissue. A more
complex situation seems likely in E19 skin, where
c-Fos appeared to be upregulated predominantly in the
suprabasal keratinocytes at the wound edge and not the
basal cells shown to express keratin 14. c-Fos positive basal
cells were observed some distance from the wound margin
however, and so repression of keratin 14 mRNA in this tissue
may involve not only Fos/Jun AP-1 heterodimers but also
coordinated binding to the keratin 14 promoter of other
members of the AP-1, ets, and AP-2 families of transcription
factors with as yet unknown wound-induced expression
profiles (Sinha et al, 2000). Indeed, the wound-associated
change in keratinocyte differentiation and control of down-
stream gene transcription by AP-1 is likely to ultimately
involve the coordinated expression of other AP-1 subunits
(i.e., junB, junD, fosB, Fra-1, Fra-2) that, along with c-Fos and
c-Jun, play a central role in skin physiology and pathology
(Eckert and Welter, 1996; Rossi et al, 1998; Angel et al, 2001).
While the potential for prolonged wound-induced c-Fos/
c-Jun expression in the epidermis of E19 fetuses to induce a
terminal differentiation pattern is consistent with the role this
family of transcription factors plays in controlling keratino-
cyte differentiation (Welter and Eckert, 1995; Lohman et al,
1997; Rutberg et al, 1997), the alternate hypothesis that
transient c-Fos/c-Jun expression in E17 skin promotes a
migratory phenotype in epidermal cells remains somewhat
speculative. To confirm the importance of AP-1 transcription
factors as initiators of the downstream, re-epithelialization
process, we examined a potential signal transduction path-
way with the capacity to mediate the wound-induced
increase in c-Fos. The p44/42 MAP kinases or ERK1 and
ERK2 activate c-fos transcription by phosphorylating the
ternary complex factors (TCFs) bound to the serum response
element in the c-Fos promoter (Whitmarsh and Davis, 1996).
Activation of ERK by injury has been associated with c-Fos
expression in intestinal epithelial cell monolayers (Dieck-
graefe et al, 1997; Go¨ke et al, 1998), although ERK activation
following wounding has not been assessed in skin.
We show here that the activation of both ERK1 and ERK2
was associated with expression of c-Fos and wound re-
epithelialization in E17 skin. That is, the MEK inhibitor U0126
abolished wound-induced ERK phosphorylation observed
5 min after wounding as well as the upregulation of c-fos
mRNA expression seen after 30 min, although it did not
inhibit wound-induced c-jun expression. Incubation of skin
with U0126 also significantly inhibited the closure of
wounds after 24 h, suggesting that wound re-epithelializa-
tion in this tissue is dependent on MAPK-mediated AP-1
activation with a specific requirement for c-Fos as one of
the proteins in the AP-1 dimer. U0126 is a well-defined,
selective MEK inhibitor that has been shown to inhibit ERK-
associated c-fos and c-jun mRNA induction and suppress
an AP-1-driven luciferase reporter construct in fibroblasts
(Favata et al, 1998). Moreover, U0126 has been well used to
demonstrate the requirement of ERK1/2 in a number of
systems (reviewed by Pearson et al, 2001). Our finding that
wound-induced c-jun expression was not inhibited by
U0126 suggests that this may be mediated by c-jun-N-
terminal kinase (JNK), a stress-activated protein kinase
(SAPK) that is not affected by U0126 at the concentrations
used in this study (Favata et al, 1998). The contention that
transient, wound-induced activation of AP-1 (via MAPK)
may regulate genes necessary for migration is supported by
the finding that an AP-1 driven, fibroblast growth factor-
inducible response element (FiRE) of the syndecan-1 gene
was activated selectively in migrating (but not proliferating)
keratinocytes at the edge of a wound in mouse skin
(Jaakkola et al, 1998). This activation was dependent on
MAPK and was initiated at the start of cell migration.
Moreover, the microinjection of antisense c-fos DNA into
endothelial cells inhibits cell migration stimulated by
wounding (Tran et al, 1999).
The AP-1-mediated control (either up- or downregula-
tion) of downstream genes such as TGFb and specific
matrix metalloproteinases (MMP) provides one potential
mechanism by which AP-1 transcription factor expression
could promote keratinocyte migration and hence re-
epithelialization in E17 skin. AP-1 regulatory sites in the
promoter of TGFb, a growth factor known to inhibit epithelial
cell migration, control its expression (Foreman et al, 1996;
Andresen et al, 1997). MMP 1 (collagenase I) and 9
(gelatinase B) also have AP-1 binding sites as primary
transcription regulatory sites in their promoters (White and
Brinckerhoff, 1995; Benbow and Brinckerhoff, 1997). These
MMPs are particularly important for degrading epidermal
cell–cell and cell–matrix connections at the wound front to
permit cellular migration. For example, increased MMP-9
mRNA expression in epithelial cells 2 h after the amputation
of axolotl limbs was found to be critical for limb regenera-
tion (Parks, 1999; Yang et al, 1999).
In conclusion, this report describes for the first time the
developmental regulation of AP-1 transcription factor
expression induced by wounding in fetal skin. Moreover, it
has begun to dissect the molecular events initiated by a
wound stimulus, with the potential to explain why skin from
E17 but not E19 fetuses can re-epithelialize an excisional
wound in the absence of dermal substrata. Elucidating the
role of transcription factors and the genes they regulate as
potential mediators of wound re-epithelialization, particu-
larly in fetal skin, will ultimately improve our understanding
of the phenomenon of ‘‘scar-free’’ regenerative healing
observed in this tissue.
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Methods
Animals Time-mated Sprague–Dawley rats (University of Ade-
laide, Australia) were used in this study. A positive mating was
identified by the formation of a vaginal plug and was taken as day 0
of gestation. Pregnant rats were killed by CO2 asphyxiation on E17
and E19 of gestation, and each fetus was removed aseptically. They
were subsequently weighed, and placed in ice-cold Dulbecco’s
minimum essential medium (DMEM, GIBCO BRL, Rockville,
Maryland). All experiments were approved by the necessary
institutional animal ethics committees and were performed in
accordance with the National Health and Medical Research
Council (NHMRC) Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes.
Culture experiments Two approaches were taken to obtain tissue
for analysis. For gene activation and wound re-epithelialization
studies where skin was assessed up to 24 h after wounding, skin
excised from fetuses and mounted on supporting rings to retain its
normal tension was used (Belford, 1997). This model, however, was
not suited to short-term experiments assessing MAPK activation
due to the time required to excise and mount the skin and because
non-wounded, time-matched controls could not be collected. To
overcome this limitation, we developed a fetal culture system that
was also used to collect samples for in situ hybridization and
immunohistochemical analysis.
Culture of fetal skin explants Wounding and culture of fetal rat
skin was undertaken as previously described with minor alterations
(Belford, 1997). Each fetus was pinned down on a dissecting board
and wounds were created within a 1 cm  1 cm region of skin on
the dorsum of the fetus. This region of skin was then excised and
mounted onto a solid support with pins to provide tension. Skin
used for gene expression studies was wounded 25 times using a
25-gauge needle, whereas a single excisional wound was created
using a blunted 19-gauge needle in skin explants to be used for
wound re-epithelialization studies. Each explant was placed in a
12-well tissue culture dish containing 4 mL of media and incubated
for up to 24 h at 371C in 5% CO2–air. Explants used for the analysis
of gene expression were snap-frozen in liquid nitrogen at the end of
the selected incubation period (in DMEM only) with control skin
snap-frozen immediately after removal from the fetus. Images of
the wound in explants used for wound re-epithelialization studies
were captured at the time of wounding and at 1, 3, 6, and 24 h
post-wounding. The size of the wound was calculated using image
analysis software and the degree of wound re-epithelialization
determined relative to the original wound area. For these studies,
explants were incubated in DMEM alone or DMEM supplemented
with 10% fetal bovine serum (FBS) plus or minus 50 mM U0126, a
specific MAPK/ERK kinase (MEK) inhibitor (Promega, Madison,
Wisconsin).
Fetal culture Experiments assessing MAPK activation were
performed on skin collected after fetal culture. Whole fetuses were
pre-incubated in media with or without U0126 (10 and 20 mM) for
10 min, and then a defined area of skin on the dorsum was
wounded 25 times with a 25-gauge needle before incubation for a
further 5 min in the same media. Care was taken to penetrate only
the skin and not to damage underlying structures. At the end of the
incubation period, the fetus was pinned down and the area of skin
encompassing the wounds was removed and snap-frozen for
subsequent western analysis. Equivalent experiments were per-
formed, but tissues were collected 30 min after wounding for
subsequent analysis of transcription factor expression. Controls
were not wounded, but otherwise received the same treatments
and were incubated for identical times as experimental fetuses.
Fetal culture was also used to obtain skin samples for in situ
hybridization and immunohistochemistry assessment of cells at the
wound edge. In these experiments, a single full thickness incision
was created down the midline of the dorsum and the fetuses were
incubated as previously described for 0.5, 1, 1.5, 3, and 6 h. The
fetuses were then fixed in 4% paraformaldehyde overnight at 41C,
processed, and embedded in paraffin. Linear wounds were
created because excisional wounds are very difficult to locate
(Belford, 1997).
Northern blot analysis Total RNA was prepared using a Quick-
Prep RNA extraction kit (Amersham Pharmacia Biotech, Castle
Hill, Australia) according to the manufacturer’s instructions and
quantitated spectrophotometrically using GeneQuant (Amersham
Pharmacia Biotech). Fifteen micrograms of RNA from each piece of
skin was size fractionated by electrophoresis on a 1% agarose–
formaldehyde gel, transferred to a Hybond-N nylon membrane
(Amersham Pharmacia Biotech), and fixed by UV cross-linking (UV
Stratalinker 1800, Stratagene, La Jolla, California). Membranes
were sequentially probed with antisense riboprobes to c-fos and
GAPDH (cDNA kindly provided by Dr R. Rodgers and Dr P.
Mackenzie respectively), which hybridized to mRNA species of 2.2
and 1.3 kb respectively, and the differentiation-specific genes
keratin 10, 14, and loricrin (mouse cDNA kindly provided by Dr S.
Yuspa). The keratin 10, 14, and loricrin probes hybridized to mRNA
species of 2.0, 1.5, and 1.6 kb respectively. Riboprobes were
generated using a Strip-EZ RNA probe synthesis kit (Ambion,
Austin, Texas) and [a-32P]UTP (GeneWorks, Thebarton, Australia),
and were used at a final concentration of 106 incorporated counts
per mL hybridization solution. Hybridization was carried out at
651C in 50% formamide, 5  SSPE, 5  Denhardts, 0.1% SDS
and 100 mg per mL sheared salmon sperm DNA, and the
membranes were washed under high stringency.
Membranes were also probed with a c-jun DNA probe derived
from a plasmid containing 2.6 kb of mouse c-jun cDNA (American
Type Culture Collection, Manassas, Virginia), which hybridized to
mRNA species of 2.7 and 3.2 kb. The c-jun probe was labeled by
random priming using a GIGAprime DNA labeling kit (Geneworks,
Thebarton, Australia) and [a-32P]dCTP (GeneWorks), and used at a
final concentration of 106 incorporated counts per mL hybridization
solution. Hybridization was carried out at 421C in ULTRAhyb
(Ambion) and membranes were washed under high stringency. All
membranes were exposed to film (Hyperfilm, Amersham Pharma-
cia Biotech) at 801C for 24 h and also to a phosphorimager
imaging plate (FUJIFILM BAS-1500, Fuji Photo Film, Tokyo, Japan).
Densitometric analysis was performed on images generated from
the phosphorimager using Scion Imaging software (Scion Corpora-
tion, Frederick, Maryland). Target gene signals were normalized to
the GAPDH signal to control for the amount of RNA loaded into
each lane. The GAPDH signal was found to be consistent with the
ethidium bromide-stained 18S rRNA band visualized on both the
gel and the membrane. To enable comparison between E17 and E19
expression, 15 mg of a pooled sample was run on each gel as an
independent control to ensure that exposure times were consistent
between membranes.
Western blot analysis Protein extracts were prepared by homo-
genizing fetal skin in ice-cold Triton lysis buffer, and equal
quantities of protein (70 mg) were separated on SDS-10%
polyacrylamide gels and transferred to a nitrocellulose membrane
(Protran, Schleicher & Schuell, Keene, New Hampshire). After
blocking with 5% skim milk, membranes were incubated with anti-
phospho extracellular signal-related kinase (ERK) antibody (Santa
Cruz Biotechnology, Santa Cruz, California) followed by incubation
with the secondary antibody (Transduction Laboratories, Lexing-
ton, Kentucky). Signals were generated using the enhanced che-
miluminescence detection system (ECL, Amersham Pharmacia
Biotech) and membranes were exposed to film (Hyperfilm,
Amersham Pharmacia Biotech) for up to 5 min. Membranes were
immediately stripped using the western blot recycling kit (Alpha
Diagnostics, San Antonio, Texas), and re-incubated with antibodies
recognizing total ERK (1 and 2) protein (Santa Cruz Biotechnology).
Densitometry was performed using Scion Imaging software (Scion
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Corporation) and the phosphorylated ERK1 and ERK2 bands were
normalized to the total ERK1 and ERK2 bands respectively.
In situ hybridization Five micron-thick sections were cut from
paraffin blocks containing whole-mount fetuses and floated onto
slides treated with 3-aminopropyltriethoxysilane (APES, Sigma,
Castle Hill, Australia). Hybridization was carried out at 521C for 16 h
using digoxigenin (DIG)-labeled c-fos antisense generated from the
c-fos cDNA template previously described using a DIG RNA
labeling kit (Roche Diagnostics, Castle Hill, Australia). Riboprobes
were used at a final concentration of 400 ng per mL and detection
was performed using a DIG nucleic acid detection kit (Roche
Diagnostics). Sections were counterstained with light green and
mounted using immu-mount (Shandon, Pittsburgh, Pennsylvania),
and images were taken using SPOT software (Diagnostic Instru-
ments, Sterling Heights, Michigan). To overcome ubiquitous, non-
specific staining when sections were incubated with a sense probe
generated from the c-fos cDNA template, labeled control RNA
provided with the DIG labeling kit was used as a negative control.
Immunohistochemistry c-Fos antibody was obtained from Santa
Cruz Biotechnology and a rabbit anti-mouse keratin 14 primary
antibody used (Dr J. Rothnagel). Biotinylated secondary antibodies
and CY3-conjugated streptavidin were all obtained from Sigma-
Aldrich (St Louis, Missouri), Indirect immunofluorescent localization
was used with a biotin–streptavidin amplification step for increased
sensitivity. Serial 4 mm sections of the paraffin wax-embedded
fetuses were cut onto snowcoat X-tra slides (Surgipath Medical
Industries, Illinois) and antigen retrieval was used to rescue
antigens masked by the fixation process (Dako, NSW, Sydney,
Australia). For immunofluorescent detection (keratin 14 and c-Fos
in E17 skin), sections were blocked in 3% normal horse serum,
incubated for 1 h at room temperature with the primary antibodies
followed by incubation with appropriate biotinylated secondary
antibodies and CY3-conjugated streptavidin. For immunoperox-
idase detection of c-Fos in E19 skin, sections were incubated with
0.5% hydrogen peroxide to quench endogenous peroxidase
activity, blocked with 10% FBS and a Biotin/Avidin blocking kit
(Vector Laboratories, Burlingame, California), and incubated over-
night with primary antibody diluted in phosphate-buffered 500 mM
NaCl (to reduce background staining (Welter and Eckert, 1995)).
Detection was achieved using biotinylated secondary antibody and
a Vectastain ABC kit (Vector Laboratories). On control sections, the
primary and secondary antibodies were omitted to determine non-
specific binding and images were captured using ImagePro Plus
(Media Cybernetics, Silver Spring, Maryland) or SPOT software.
Data analysis At least three replicates were performed for each
experiment and combined data are presented as mean  SEM.
Two-way analysis of variance (ANOVA) was performed on expres-
sion profile data to determine interactions between time and
gestational age followed by a post hoc Tukey test (all pairwise
comparison) to isolate differences between time points and age.
The ERK and wound closure data were analyzed by one-way
ANOVA followed by post hoc t tests applied using either Dunnett’s
method (multiple comparison vs the control group) or the Tukey
test. Data that were not normally distributed were transformed prior
to running the ANOVA. po0.05 was considered to be significant.
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